Close

Morgan Stanley Upgrades Quest Diagnostics (DGX) to Overweight; Re-Rating on Contract Awards

May 29, 2018 7:31 AM EDT Send to a Friend
(Updated - May 29, 2018 7:32 AM EDT)(updated to correct firm name)Morgan Stanley upgraded Quest Diagnostics (NYSE: DGX) from Equal-weight ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login